Advertisement
Monday, Sep 27, 2021
Outlook.com
Outlook.com

Serum Institute Of India Gets Notice After Oxford Covid Vaccine Trial Paused

The show-cause notice was issued to the Serum Institute of India following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold.

Serum Institute Of India Gets Notice After Oxford Covid Vaccine Trial Paused
Representational image
Serum Institute Of India Gets Notice After Oxford Covid Vaccine Trial Paused
outlookindia.com
2020-09-10T11:31:08+05:30

The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate for COVID-19 in other countries and also for not submitting casualty analysis of the "reported serious adverse events".

The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a UK participant had an adverse reaction to it.

The Drugs Controller General of India, Dr V G Somani, in his show-cause notice has asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials of the vaccine candidate in the country be not suspended till patient safety is established.

Also Read | Plasma Therapy Not Beneficial In Reducing Covid Deaths: ICMR Study

"Whereas, Serum Institute of India Pvt Ltd, Pune, till now has not informed the central licensing authority regarding pausing the clinical trial carried out by AstraZeneca in other countries and also not submitted casualty analysis of the reported serious adverse event with the investigational vaccine for the continuation of phase 2 and 3 clinical trials of the subject vaccine in the country in light of the safety concerns," said the show-cause notice.

"In view of the above, I Dr V G Somani, Drugs Controller General of India and Central Licensing Authority hereby give you an opportunity to show cause as provided under rule 30 of the New Drugs and Clinical Trials Rules, 2019, why the permission granted to you August 2 shall not be suspended till patient safety is established," the notice further said.

The DGCI sought an immediate reply, saying else "it shall be construed that you have no explanation to offer and action deemed fit will be taken against you".

In the show-cause notice, the drug regulator also mentioned that the clinical trials have been put on hold across countries where they were conducted i.e. USA, UK, Brazil and South Africa.

Regarding the show cause notice issued by DCGI, Serum Institute of India (SII) said in a statement, "We are going by DCGI's direction and so far were not told to pause the trials. If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol."

Also Read: UK Company Pauses Covid Vaccine Trial After 'Unexplained' Illness In Volunteer

Last month, the DCGI had granted permission to the Pune-based SII to conduct Phase 2 and 3 human clinical trials of the coronavirus vaccine candidate.

AstraZeneca, a British-Swedish biopharmaceutical giant in a tie-up with the Oxford University to produce the vaccine, described the pause of trials as a "routine" one following what was "an unexplained illness".  

Earlier in the day, SII which has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for COVID-19, said it is continuing with the trials in India.

Commenting on the recent reports on AstraZeneca halting the trials in the UK, SII said in a statement, "We can't comment much on the UK trials, but they have been paused for further review and they hope to restart soon."

It further said, "As far as Indian trials are concerned, it is continuing and we have faced no issues at all."

Advertisement

Outlook Newsletters

Advertisement

Read More from Outlook

Bharat Bandh: 18 Trains Cancelled As Farmers' Agitation Brings Traffic To Halt In Haryana, Punjab

Bharat Bandh: 18 Trains Cancelled As Farmers' Agitation Brings Traffic To Halt In Haryana, Punjab

Punjab and Haryana state highways are closed, High Courts in both states have put a stay on the physical hearings, bus services have come to a standstill.

PM Modi Launches National Digital Mission To Ensure Health IDs For All: Here Is How It Works

PM Modi Launches National Digital Mission To Ensure Health IDs For All: Here Is How It Works

The Ayushman Bharat Digital Mission is being implemented in a pilot phase in six Union Territories at present, and it has been rolled out by PM Narendra Modi for entire nation today.

‘Sports NFTs Are A Movement, Not Just A Meme’

‘Sports NFTs Are A Movement, Not Just A Meme’

The sports NFT market is brand new with tremendous potential and is growing fast, says Sidarttha Bezbora.

In Kashmir, Each One A Kabul Expert

In Kashmir, Each One A Kabul Expert

Long before the fall of Kabul on August 15 and before the news channels became keen on its unfolding, Kashmiris have been keeping eye on Afghanistan.

Advertisement